The metabolism of Acetylsalicylic acid can be decreased when combined with Efavirenz. The risk or severity of adverse effects can be increased when Tranilast is combined with Acetylsalicylic acid. Acetylsalicylic acid may decrease the antihypertensive activities of Amiloride. The serum concentration of Acetylsalicylic acid can be increased when it is combined with Mifepristone. Acetylsalicylic acid may increase the hypoglycemic activities of Saxagliptin. The risk or severity of adverse effects can be increased when Naftifine is combined with Acetylsalicylic acid. Acetylsalicylic acid may increase the neuroexcitatory activities of Trovafloxacin. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desoximetasone. Acetylsalicylic acid may decrease the antihypertensive activities of Imidapril. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluprednidene. The risk or severity of adverse effects can be increased when Fenoprofen is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with 5-androstenedione. Acetylsalicylic acid may decrease the antihypertensive activities of Platelet Activating Factor. Acetylsalicylic acid may decrease the antihypertensive activities of Spirapril. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tinzaparin. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone. The therapeutic efficacy of Dinoprost can be decreased when used in combination with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Valdecoxib. The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Eptifibatide is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Kebuzone. The risk or severity of adverse effects can be increased when Olopatadine is combined with Acetylsalicylic acid. Acetylsalicylic acid may increase the anticoagulant activities of Fluindione. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with 16-Bromoepiandrosterone. The metabolism of Acetylsalicylic acid can be decreased when combined with Sildenafil. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desmoteplase. Acetylsalicylic acid may decrease the excretion rate of Zoptarelin doxorubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Treprostinil is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Apixaban. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Propacetamol. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alclometasone. Acetylsalicylic acid may decrease the excretion rate of Sabarubicin which could result in a higher serum level. Nefazodone may increase the antiplatelet activities of Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Acetylsalicylic acid. Sodium phosphate may increase the nephrotoxic activities of Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Tolmetin is combined with Acetylsalicylic acid. Acetylsalicylic acid may decrease the excretion rate of Spectinomycin which could result in a higher serum level. Acetylsalicylic acid may increase the anticoagulant activities of Protocatechualdehyde. Etoperidone may increase the antiplatelet activities of Acetylsalicylic acid. The metabolism of Acetylsalicylic acid can be decreased when combined with Etravirine. Acetylsalicylic acid may increase the neuroexcitatory activities of Rosoxacin. Acetylsalicylic acid may decrease the antihypertensive activities of Zofenopril. The risk or severity of adverse effects can be increased when Telmisartan is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Antipyrine. The risk or severity of adverse effects can be increased when Etanercept is combined with Acetylsalicylic acid. The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Aprotinin. The risk or severity of adverse effects can be increased when Tasosartan is combined with Acetylsalicylic acid. The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Tarenflurbil. Acetylsalicylic acid may decrease the antihypertensive activities of Timolol. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Astaxanthin. Acetylsalicylic acid may decrease the antihypertensive activities of Bufuralol. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Lornoxicam. The metabolism of Acetylsalicylic acid can be decreased when combined with Voriconazole. The metabolism of Acetylsalicylic acid can be increased when combined with Aprepitant. The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with anecortave acetate. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with 19-norandrostenedione. The serum concentration of Acetylsalicylic acid can be increased when it is combined with Lumacaftor. Acetylsalicylic acid may increase the hypoglycemic activities of Miglitol. Acetylsalicylic acid may increase the antiplatelet activities of Ticagrelor. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alclofenac. The metabolism of Acetylsalicylic acid can be decreased when combined with Crisaborole. Acetylsalicylic acid may decrease the excretion rate of Neomycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with ME-609. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prasterone. Acetylsalicylic acid may decrease the antihypertensive activities of Enalaprilat. Acetylsalicylic acid may decrease the antihypertensive activities of Penbutolol. Zimelidine may increase the antiplatelet activities of Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Benzydamine. Acetylsalicylic acid may increase the neuroexcitatory activities of Grepafloxacin. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Deoxycholic Acid. Acetylsalicylic acid may increase the anticoagulant activities of Edetic Acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Cortexolone 17α-propionate. Acetylsalicylic acid may increase the neuroexcitatory activities of Flumequine. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Oleoyl-estrone. Acetylsalicylic acid may increase the neuroexcitatory activities of Norfloxacin. Acetylsalicylic acid may decrease the antihypertensive activities of Rescinnamine. Acetylsalicylic acid may decrease the excretion rate of Apramycin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ditazole. Acetylsalicylic acid may increase the hypoglycemic activities of Nateglinide. Acetylsalicylic acid may decrease the antihypertensive activities of Nadolol. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Pregnenolone. The serum concentration of the active metabolites of Carisoprodol can be increased when Carisoprodol is used in combination with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Estrone sulfate. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Equilin. The risk or severity of adverse effects can be increased when Defibrotide is combined with Acetylsalicylic acid. Acetylsalicylic acid may decrease the excretion rate of Daunorubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fenbufen. The therapeutic efficacy of Gemeprost can be decreased when used in combination with Acetylsalicylic acid. The serum concentration of Vancomycin can be increased when it is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Aceclofenac. The risk or severity of adverse effects can be increased when Tenoxicam is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Medrysone. Acetylsalicylic acid may increase the hypoglycemic activities of Glimepiride. The risk or severity of adverse effects can be increased when Sacubitril is combined with Acetylsalicylic acid. Pentoxifylline may increase the antiplatelet activities of Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluocinolone Acetonide. The metabolism of Acetylsalicylic acid can be decreased when combined with Quinine. Acetylsalicylic acid may increase the hypoglycemic activities of Canagliflozin. The risk or severity of adverse effects can be increased when Zileuton is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Loxoprofen. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Difluprednate. The risk or severity of adverse effects can be increased when Meloxicam is combined with Acetylsalicylic acid. The serum concentration of Acetylsalicylic acid can be increased when it is combined with Deferasirox. Acetylsalicylic acid may decrease the antihypertensive activities of Talinolol. Acetylsalicylic acid may increase the anticoagulant activities of Ethyl biscoumacetate. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Benoxaprofen. Acetylsalicylic acid may increase the neuroexcitatory activities of Nalidixic Acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desonide. Acetylsalicylic acid may decrease the antihypertensive activities of Befunolol. Acetylsalicylic acid may decrease the excretion rate of Amrubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Loteprednol. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Flurandrenolide. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Clodronic Acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etodolac. Acetylsalicylic acid may decrease the antihypertensive activities of Trandolapril. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Omacetaxine mepesuccinate. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Corticosterone. Acetylsalicylic acid may increase the hypoglycemic activities of Empagliflozin. The therapeutic efficacy of Quinethazone can be decreased when used in combination with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Dipyridamole is combined with Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etoricoxib. Glucosamine may increase the antiplatelet activities of Acetylsalicylic acid. The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone. Acetylsalicylic acid may decrease the antihypertensive activities of Cilazapril. The risk or severity of adverse effects can be increased when Milrinone is combined with Acetylsalicylic acid. The metabolism of Acetylsalicylic acid can be decreased when combined with Pioglitazone.